Identifying an early indicator of drug efficacy in patients (pts) with metastatic colorectal cancer (mCRC) - a prospective evaluation of circulating tumor cells (CTC), 18F-fluorodeoxyglucose positron-emission tomorgraphy (PET) and the RECIST criteria

B.B. Ma, A.D. King, L. Leung, A. Poon, K. Wang, H. Loong, R. Ho, F. Mo, W.M. Ho, C. Chan, A.T. Chan, Sze Chuen Cesar Wong

Research output: Unpublished conference presentation (presented paper, abstract, poster)Conference presentation (not published in journal/proceeding/book)Academic researchpeer-review

Original languageEnglish
Publication statusPublished - 2014
EventAmerican Society of Clinical Oncology. Meeting -
Duration: 1 Jan 2014 → …


ConferenceAmerican Society of Clinical Oncology. Meeting
Period1/01/14 → …

Cite this